Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy

A Pilot Project to Evaluate Feasibility and Patient Experience of Prehabilitation Care for Women With Advanced Ovarian Cancer Undergoing Neoadjuvant Chemotherapy

The purpose of this study is evaluate whether a prehabilitation program is feasible and useful for women with advanced ovarian cancer receiving chemotherapy in preparation for debulking surgery.

Inclusion Criteria:

• Subjects must be diagnosed with Stage III or Stage IV ovarian carcinoma (which includes primary peritoneal carcinoma or fallopian rube carcinoma)
• All subjects must be enrolled within 90 days of diagnosis
• No prior treatment for ovarian carcinoma
• All subjects have agreed to a treatment plan of neoadjuvant chemotherapy and subsequent planned interval debulking surgery with an MSKCC surgeon
• Participants must be initiating treatment at Gynecologic Medical Oncology clinics at MSKCC Manhattan
• Proficiency in English in the determination of the investigators of by patient self-report

Exclusion Criteria:

• Patient under age 18
• Prior treatment for ovarian cancer
• Second opinion visit only
• Immediate surgery plan without neoadjuvant treatment
• No intended surgical plan
• Chemotherapy administration exclusively planned at MSKCC regional site
• Patient unwilling to sign consent